The phase 1 @moderna_tx #coronavirus vaccine results gave me a little hope today, but then I looked at the racial and ethnic demographic breakdown of the subjects... and then thought about which communities have been the most disproportionately impacted by the pandemic.

Then I thought about the June 11 letter to @US_FDA commissioner Hahn from the Alliance of Multicultural Physicians that “strongly recommended that FDA provide clear guidance to all
sponsors of medical products directed at COVID-19 to assure inclusion that provides the basis....”

...for clinically meaningful data to address the needs of a diverse America.”

Even #Remdesivir showed shortened recovery times only in white patients, but not in Black, Asian or Hispanic subgroups, likely because of inadequate number of participants from these racial groups.

Disclaimer: No, this tweet is *not* referring to or promoting race-based medicine. These trials must be designed and managed using a racial equity lens or they will only perpetuate current racial health inequities.